‘Stribild’ unveiling its research for the first time stated “We will lead HIV treatment”
‘Stribild,’ which has opened the new era of single-tablet complex drugs in the HIV/AIDS treatment, has continuously expanded its position. Although relatively starting as a last mover, the product has been increased in frequency of selection with its interesting clinical study results to doctors....
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
